Ondine Biomedical (FRA:VF5) Price-to-Free-Cash-Flow : N/A (As of May. 22, 2025)

Ondine Biomedical Price-to-Free-Cash-Flow Chart

Ondine Biomedical Annual Data
	Trend	Dec08	Dec09	Dec10	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Price-to-Free-Cash-Flow		Get a 7-Day Free Trial					-	-	-	-	-

Ondine Biomedical Semi-Annual Data
	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Price-to-Free-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Ondine Biomedical's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Ondine Biomedical's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ondine Biomedical's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ondine Biomedical's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Ondine Biomedical's Price-to-Free-Cash-Flow falls into.

Ondine Biomedical Price-to-Free-Cash-Flow Calculation

Ondine Biomedical's Price-to-Free-Cash-Flow ratio for today is calculated as

Ondine Biomedical's Share Price of today is €0.076.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ondine Biomedical's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Ondine Biomedical  (FRA:VF5) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Ondine Biomedical Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Ondine Biomedical's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Ondine Biomedical Business Description